2011
DOI: 10.1002/mnfr.201000558
|View full text |Cite
|
Sign up to set email alerts
|

Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease

Abstract: Not all plant proteins are equally protective in experimental kidney disease and associated cardiac hypertrophy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 27 publications
(12 citation statements)
references
References 59 publications
(58 reference statements)
0
12
0
Order By: Relevance
“…In conclusion, different dietary habits are known to have an impact on the host wellbeing by influencing, among others, glycaemic response [44], modulation of atherogenic pathways [45], risk for metabolic syndrome [46], and renal disease progression [47]. Moreover, fiber consumption is apparently inversely associated with cardiovascular disease and cancer mortality [48].…”
Section: Discussionmentioning
confidence: 99%
“…In conclusion, different dietary habits are known to have an impact on the host wellbeing by influencing, among others, glycaemic response [44], modulation of atherogenic pathways [45], risk for metabolic syndrome [46], and renal disease progression [47]. Moreover, fiber consumption is apparently inversely associated with cardiovascular disease and cancer mortality [48].…”
Section: Discussionmentioning
confidence: 99%
“…FPI (from Section 3.2.1), 2.5% FPH and 3.0% FPH samples obtained by the digestion of FPI with 2.5% and 3.0% thermoase GL-30, respectively, the membrane fractions (<1, 1–3, 3–5 and 5–10 kDa in size) from the ultrafiltration of each of the two FPH samples, as well as captopril were each dissolved in phosphate-buffered saline (PBS), pH 7.2. The samples (each at 200 mg/kg BW), PBS (used as negative control), and captopril (10 mg/kg BW; used as positive control) were administered to the SHR by oral gavage followed by measurement of systolic blood pressure (SBP) by tail-cuff plethysmography (Mouse Rat Tail Cuff Blood Pressure System, IITC Life Science, Woodland Hills, CA, USA) at 2, 4, 6, 8 and 24 h in rats mildly anesthetized for 4 min with 4% isoflurane [9,32]. The gas flow chamber, maintained at 37 °C, was designed to include positive pressure ventilation in order to sustain independent ventilatory function and attenuate isoflurane-induced depression of spontaneous ventilation in the animals.…”
Section: Methodsmentioning
confidence: 99%
“…Following oral administration by syringe gavage, the effects of samples on SBP were compared to that of captopril. SBP was measured by tail-cuff plethysmography at 2, 4, 6, 8 and 24 h (post oral administration of samples) in mildly anesthetized rats according to the method of Aukema et al [19]. In order to mitigate the SBP depression effect of isofluorane, the gas flow was optimized such that rats became conscious usually within 3-4 min after removal from the chamber, which provided enough time to perform the blood pressure measurement.…”
Section: Shrs and Measurement Of Systolic Blood Pressurementioning
confidence: 99%